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Abstract 
IQ-motif-containing GTPase-activating protein 1 (IQGAP1), also known as p195, is a 
ubiquitously expressed protein that is a member of the IQGAP family of scaffolding proteins. 
Due to the numerous binding partners IQGAP1 interacts with, this protein has been found to 
regulate a diverse range of cellular processes including: cell migration, cell proliferation, 
cytoskeletal dynamics, and intracellular signaling. Previous studies indicated that IQGAP1 binds 
to phosphoinositides, but the exact nature of the binding is not well characterized. Interactions 
between IQGAP1 and phosphoinositides can be characterized by in-vitro studies using purified 
proteins and phosphoinositide containing model membranes. Because IQGAP1 is a large multi-
domain protein (190kDa), purifying it presented various challenges, including high protein 
degradation. Therefore, IQGAP1-C, a truncated protein that consists of several C-terminal 
domains that includes the proposed PIP binding site, was instead purified. In this study, we show 
that we were able to purify the IQGAP1-C protein and characterize its interaction with lipids. 
Using protein/lipid vesicle binding studies, we have obtained evidence of 
IQGAP1C/phosphoinositide interaction.  
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Introduction 
IQGAPs are a family of scaffolding proteins that regulate a diverse range of cellular processes 
due to the many partners it is interacting with. Cellular processes that are affected by this protein 
include cell migration, cell proliferation, intracellular signaling, cytoskeletal dynamics, 
cytokinesis, and vesicle trafficking. Humans have been shown to express three related isoforms 
of IQGAP which show a high degree of homology, and these are IQGAP1, IQGAP2, and 
IQGAP3. This family of proteins exhibits five major domains(Choi and Anderson 2016, 2017).  
 
Figure 1-Proposed mechanism suggests that phosphorylation at Serine 1443 relieves N- and C- termini 
interactions which in turn leads to the partial opening of the protein. This partial opening allows PIPKI 
access to the binding site of the IQ domain. It is then theorized that either binding of Cdc42 and Rac1 on the 
GRD domain or binding of PI4,5P2 on the RGCT domain fully opens the structure(Choi and Anderson 2016). 
Based on previous studies, the mechanism of activation of IQGAP1 has been theorized but not 
proven experimentally (Figure 1). As can be seen in Figure 1, there are three proposed states: 
inhibited, partially open, and fully open. The proposed mechanism suggests that phosphorylation 
at Serine 1443 relieves N- and C- termini interactions which in turn leads to the partial opening 
of the protein. This partial opening allows PIPKI access to the binding site of the IQ domain 
(Choi et al. 2013). It is then theorized that either binding of Cdc42 and Rac1 on the GRD domain 
or binding of PI4,5P2 to the RGCT domain fully opens the structure. IQGAP1 binding sites have 
been studied, but not extensively. As seen in Figure 2, the various molecules and proteins that 
bind to each particular domain can be seen (Choi and Anderson 2016). 
 
Figure 2- Domains and Homology between IQGAP1 and IQGAP2. Both IQGAP1 and IQGAP2 contain five 
different domains that have a different homology percent that can be seen above. Each domain has binding 
sites in which other enzymes and molecules can bind. The table shows some of the known binding sites of 
IQGAP1 (Choi et al. 2013). 
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Background 
IQGAP1, which is also known as p195, is a ubiquitously expressed protein that is part of the 
IQGAP family of scaffolding proteins(Katie B. Shannon 2012; Hedman, Smith, and Sacks 
2015). IQGAP1 is involved in a wide range of cellular processes, some of which include: 
organization of the actin cytoskeleton, cellular adhesion, regulation of the cell cycle, and 
transcription (Hedman, Smith, and Sacks 2015; Choi et al. 2013). 
History  
IQGAP1 was first discovered in 1994. It was originally hypothesized that IQGAP1 would act as 
a GTPase activating protein (GAP). Despite the initial hypothesis, IQGAP1 does not possess a 
GAP function (Johnson, Sharma, and Henderson 2009). A GTPase activating protein switches 
RasGTPases from the active GTP-GDP bound forms. RAC1 and CDC42 are bound with a much 
higher affinity than the RasGTPase GDP-bound form. Although IQGAP1 does not possess a 
GAP function, it still stabilizes the active form in vivo (Hedman, Smith, and Sacks 2015). 
Scaffolding Proteins 
There are an estimated one billion protein molecules in mammalian cells, with approximately 10 
percent of these involved in signal transduction. Cells need to be able to accurately and 
efficiently process the vast array of signaling information. Cells can achieve this specificity by 
organizing discrete subsets of proteins in compartments(Choi and Anderson 2016; Garbett and 
Bretscher 2014). Subcellular compartments, such as organelles, can organize these proteins into 
a smaller space. Another solution to this problem was discovered about 15 years ago when 
scaffolding proteins were found. Scaffolding proteins can assemble functionally interacting 
proteins into specific complexes. Scaffolding proteins coordinate the physical assembly of a 
signaling pathway or network. Scaffolding proteins have likely evolved independently and are a 
diverse set of proteins. Scaffolding proteins are usually composed of multiple modular 
interaction domains, or motifs (Garbett and Bretscher 2014). 
 
Figure 3- IQGAP1 has been theorized to act as a scaffolding protein and efficiently coordinate 
PtdIns(3,4,5)P3 generation and downstream signaling(Garbett and Bretscher 2014). 
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Scaffolding proteins can physically direct communications between signaling partners in diverse 
ways. One of the more primitive methods in which scaffolding proteins do this is through the 
tethering of partner molecules. The tethering of two different substrates increases the effective 
concentration of the two different substrates (Garbett and Bretscher 2014; Good, Zalatan, and 
Lim 2011). There will also be a large entropic advantage if the scaffolding protein binds and 
orients two weakly-interacting proteins. The reaction rates of the scaffold tether are affected by 
the length and the flexibility of the scaffold. Factors that affect reaction rates of scaffold proteins 
are only beginning to be systematically explored (Garbett and Bretscher 2014). 
Mechanisms such as tethering are thought to be related to other more sophisticated mechanisms 
such as allosteric regulation. Allosteric regulation precisely controls the specificity and the 
dynamics of the information that is being transferred. They can also control more complex 
networks by integrating feedback loops and regulatory controls. These types of proteins are very 
versatile because of their modularity (Good, Zalatan, and Lim 2011). Cells use these proteins to 
diversify their behaviors 
and to evoke new 
responses. This happens 
because of their modularity, 
which allows protein 
interaction with the scaffold 
to generate new signaling 
pathways. One way in 
which these proteins are 
utilized is in pathogens 
(Good, Zalatan, and Lim 
2011). Pathogens use 
scaffold proteins to their 
advantage by rewiring host signal pathways to avoid host defenses. Pathogens that are able to do 
this more efficiently and more effectively are more virulent (Good, Zalatan, and Lim 2011).  
Scaffolding proteins have such critical roles in cellular signaling, which is why they are of such 
interest to be studied. Scaffolding proteins are being used to create signaling and metabolic 
pathways in laboratories that are predictable. Scaffold proteins were originally thought to be 
stable, but recently it has been found that they can actually be quite dynamic (Good, Zalatan, and 
Lim 2011; Garbett and Bretscher 2014).  
Figure 4-A) Scaffolds can allosterically modulate the substrate so that 
it becomes active when on the scaffold.  B) An example of how 
scaffolds are able to allosterically modulate a kinase (Garbett and 
Bretscher 2014. 
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IQGAP Protein Family 
IQGAPs have been found to be conserved in 
yeast cells to human cells. IQGAP1 is the 
most studied of the IQGAP family proteins. 
Although IQGAPs are found in yeasts, these 
IQGAPs are only homologs, which contain 
some, but not all of the domains of the full 
length IQGAPs which are found in 
mammalian cells.  The sequences of IQGAP1, 
IQGAP2, and IQGAP3 are  compared  in 
Figure 5 (Katie B. Shannon 2012).  
 
 
IQGAPs in Yeast Cells 
Recent studies have shown that some functions of IQGAP 
in yeast cells are cytokinesis, cell motility, and cell 
signaling. SpRng2 is part of the IQGAP family, and it is 
found in Schizosaccharomyces pombe. 
Schizosaccharomyces pombe is known to have one 
IQGAP. Studies of Schizosaccharomyces pombe show 
that the molecular function of Rng2 in fission yeast is to 
recruit F-actin and other proteins to the actomyosin ring 
(Katie B. Shannon 2012). Rng2 is also important in 
recruiting other proteins necessary for cytokinesis to the 
cortical nodes. Rng has a number of roles throughout the 
assembly and contraction of the actomyosin ring. Rng2 
may act as a scaffold and stabilize and recruit myosin and 
its light chain (Katie B. Shannon 2012). 
Iqg1/Cyk1 is another IQGAP protein that is found in Saccharomyces cerevisiae, budding yeast. 
Saccharomyces cerevisiae like Schizosaccharomyces pombe only has a single IQGAP family 
member. Iqg1 functions to recruit actin to the contractile ring through the CHD domain. It is also 
required for localizing Myo1 to the contractile ring during cytokinesis (Katie B. Shannon 2012). 
Filamentous Fungi Candida albicans and Ashbya gossypii IQGAPs were first discovered by 
homology. There IQGAPs are known as AgCyk1 and ScIqg1. AgCyk1 and ScIqg1 are 30% 
Figure 5- IQGAP proteins present in various eukaryotes. 
Mammals similarily share five domains: CHD, WW 
domain, IQ domain, GRD, and RasGAP_C-terminus 
(RGCT) (Katie B. Shannon 2012).  
 
Figure 6- Various IQGAPs found in several 
types of yeast cells. This figure shows how 
similar and conserved IQGAP is. (Shannon 
2012). 
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identical, and similar to other yeast IQGAPs, they are necessary for taking part in the formation 
of actin rings (Jameson et al. 2013). 
 Mammalian IQGAPs 
There are three types of IQGAPs that are found in 
mammalian cells, which are IQGAP1, IQGAP2, 
and IQGAP3. These three IQGAPs share a high 
level of homology. IQGAP1 has been shown to 
have numerous roles in mammalian cells. Some of 
the processes in which IQGAP1 is involved in are 
the establishment of cell polarity, cell adhesion, 
phagocytosis, and motility. IQGAP1 is also present 
in the MAPK cascade, in which it acts as a sgnaling 
scaffold. The functions of IQGAP2 and IQGAP3 
are less understood (Katie B. Shannon 2012).  
IQGAP1 
IQGAP1 is a multi-domain protein that mediates the formation of a variety of protein complexes 
that are required for various cellular functions. Some of the cellular functions that IQGAP1 has 
been experimentally shown to mediate include regulation of cytokinesis, cell migration and cell-
cell adhesion. IQGAP1 has also been shown to scaffold signaling molecules and proteins which 
are part of the mitogen-activated protein kinase (MAPK) pathway. IQGAP1 also interacts with 
Ca2+/calmodulin and actin to regulate the actin cytoskeleton. IQGAP1 has also been shown to 
affect the PI3K/Akt pathway which will be further discussed  (Hedman, Smith, and Sacks 2015; 
Briggs and Sacks 2003a, 2003b). 
Domains 
IQGAP1 is a 190kDa protein that contains five distinct domains. The N-Terminus contains a 
calponin homology domain, which is composed of 114 amino acids. The calponin homology 
domain mediates actin binding and also binds calponin (Hedman, Smith, and Sacks 2015). Next, 
there is a coiled coil region that is composed of 520 amino acids, which is followed by the WW 
domain. The WW doman, or poly-proline protein-protein domain contains two functionally 
conserved Tryptophan (W). Tryptophan residues associate with the proline-rich regions of other 
proteins, thus the name poly-proline protein-protein domain. Following the WW Domain, there 
is an IQ domain which contains four IQ motifs. The IQ domains are known to bind calmodulin. 
Calmodulin is a calcium sensor that binds and regulates a variety of proteins. Following the IQ 
domain is a RasGap-Related Domain (GRD), which is highly similar to the functional subunit of 
Ras GTPase activating proteins (GAP), however it does not possess a GAP function. The GRD 
domain is known to bind the Rho GTPases: CDC42 and RAC1 and stabilizes the GTP bound 
proteins in their active state. Following GRD is the RasGAP Carboxy Terminal (RGCT) 
sequence. The RGCT sequence is known to bind beta-catenin and E-cadherin (Hedman, Smith, 
and Sacks 2015; Choi and Anderson 2017). 
Figure 7-IQGAP1, 2, and 3 have share a high 
degree of homology (Shannon 2012. 
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Figure 8- IQGAP1 contains a calponin homology domain (CHD) in the N-terminus that binds F-actin, 
internal repeats (IR) that form a coiled-coil region required for dimerization, a tryptophan repeat motif 
(WW) of unknown function, IQ domains that bind calcium-binding proteins, a GAP-related domain (GRD) 
that interacts with Cdc42 and Rac1, and a Ras-GAP C-terminus (RGCT) homology domain (Hedman, Smith, 
and Sacks 2015). 
Expression 
Expression analysis of IQGAP1 in human tissues has shown that IQGAP1 is more or less 
ubiquitously expressed. IQGAP1 can be found in the nucleus, plasma membrane, and the 
cytoplasm. Analysis of expression in cancers has shown that IQGAP1 is often overexpressed. 
IQGAP1 has been observed to be at the invasive front of the neoplasm in more aggressive 
cancers, which could indicate a possible role in the mobilization of these cancerous cells. In 
comparison with IQGAP1, IQGAP2 is mostly found in the liver, but it can also be found in the 
testis, stomach, kidneys, prostate, salivary glands, and platelets (Jameson et al. 2013). 
 
Figure 9- Protein expression of IQGAP1 in different organ types. IQGAP1 is more or less ubiquitously 
expressed, but expression levels differ depending on the organ type 
(http://www.proteinatlas.org/ENSG00000140575-IQGAP1/tissue). 
Location within the Cell 
 
Figure 10- IQGAP1 is located in the 
membrane of the cell which which is 
shown in this figure. This 
information is important for the 
purification process. 
https://www.proteinatlas.org/ENSG0
0000140575-
IQGAP1/antibody#western_blot 
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Cellular Function 
Due to the large number of binding partners that IQGAP1 has, it is not suprising that IQGAP1 
takes part in a wide range of cellular functions. 
Regulation of Cell-Cell Adhesion 
Cadherins are a large group of molecules that mediate cell-cell adhesion. The mechanism by 
which cadherins are engaging is Ca2+ dependent, homophilic and involves trans interactions. 
IGQAP1 regulates cell-cell adhesion by interacting with beta-catenin. IQGAP1’s interaction with 
beta-catenin causes alpha-catenin to dissociate from the cadherin-catenin complex. IQGAP1 
negatively inhibits cell-cell adhesion in this way, but IQGAP1 can also positively regulate cell-
cell adhesion by interacting with Rac1 and Cdc42. The interaction of these two proteins inhibits 
IQGAP1 from interacting with beta-catenin. This positive and negative regulation of cell-cell 
adhesion creates a dynamic equilibrium. Therefore, cells can alter their cell-cell adhesion by 
forming these two different 
complexes (Hedman, Smith, and 
Sacks 2015; Briggs and Sacks 
2003a). 
 
 
 
 
Figure 11- Cellular processes that are regulated by this protein include cell migration, cell proliferation, 
intracellular signaling, cytoskeletal dynamics, cytokinesis, and vesicle trafficking. 
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Cell polarization 
CLIP-170 is a protein that has been shown to associate with microtubules, and also interacts with 
IQGAP1. It has been proposed that Rac1/Cdc42 marks spots which are subsequently targeted by 
CLIP-170- IQGAP1 complexes. This targeting creates a polarized microtubule array and leads to 
cell polarization (Noritake et al. 2005). Experimentally, this was supported with the fact that 
IQGAP1 colocalizes with actin filaments at the polarized leading edge, to which CLIP-170 and 
microtubules are targeted. The interaction between CLIP-170 and IQGAP1 is enhanced by 
Rac1/Cdc42(Hedman, Smith, and Sacks 2015). 
Migration mechanisms 
IQGAP1 has been shown to accumulate at the leading edge of directionally migrating cells. Once 
at the leading edge IQGAP1 crosslinks actin filaments. IQGAP1 has been proven to influence 
cell migration (Briggs and Sacks 2003b). Knockout of IQGAP1 has been proven to reduce cell 
motility. IQGAP1 and APC have been shown to directly interact, and have been experimentally 
shown to colocalize at the leading edge along with Rac1 and Cdc42. IQGAP1and APC form a 
complex, that when complexed along with Rac1 and Cdc42 form a tripartite (Hedman, Smith, 
and Sacks 2015; Briggs and Sacks 2003b). 
The mechanism by which IQGAP1 causes cell migration is theorized but not experimentally 
proven. First, Rac1 and Cdc42 are activated by extracellular signals through receptors at the 
leading edge of the cell migration. Second, Rac1 and Cdc42 induce polymerizationof actin 
filaments. Rac1 and Cdc42 also mark spots which will then be targeted by IQGAP1. IQGAP 
(Noritake et al. 2005)1 then links APC to actin filaments and captures the positive end of the 
microtubule with CLIP-170. APC will then stabilize the microtubules, which is necessaryto 
create a meshwork of stable actin (Hedman, Smith, and Sacks 2015; Briggs and Sacks 2003a).  
 
  
 
Figure 13- The mechanism by which IQGAP1 causes cell migration is theorized but not experimentally 
proven. First, Rac1 and Cdc42 are activated by extracellular signals through receptors at the leading edge of 
Figure 12- IQGAP1 plays a key role in regulating E-cadherin-mediated cell adhesion. Higher levels of 
activated Rac1, leads to higher interaction between IQGAP1 and Rac1, which decreases the interaction 
of IQGAP1 with beta-catenin, which leads to strong adhesion. Weak adhesion is caused by higher 
amounts of inactive Rac1, which leads a higher degree of interaction between IQGAP1 and beta catenin 
(Hedman, Smith, and Sacks 2015; Briggs and Sacks 2003a). 
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the cell migration. Second, Rac1 and Cdc42 induce polymerizationof actin filaments. Rac1 and Cdc42 also 
mark spots which will then be targeted by IQGAP1. IQGAP1 then links APC to actin filaments and captures 
the positive end of the microtubule with CLIP-170. APC will then stabilize the microtubules, which is 
necessaryto create a meshwork of stable actin (Hedman, Smith, and Sacks 2015). 
 
Physiological Function  
Roles of IQGAP1, with respect to physiological function have been derived from knockout mice 
and cultured cells. This research has shown that IQGAP1 has many physiologically roles. In the 
following section, the physiological functions in various organs are being described. 
 
Cardiac functions 
Heart morphology is regulated by intracellular 
signaling pathways (White, Erdemir, and Sacks 
2012). Excessive pressure activates these 
intracellular signaling pathways. Observation of 
IQGAP1 null mice have revealed that the mice 
initially have normal basal heart function, but 
prolonged pressure leads to cardiac remodeling that 
is unfavorable. Decreased contractility, thinning of 
the ventricular walls, and increased apoptosis are a 
few of the unfavorable remodeling processes that 
occur with a lack of IQGAP1 present. IQGAP1 
modulates ERK and Akt activation in response to 
cardiac pressure. Long term chronic pressure 
overload of mouse cardiomyocytes stimulates the 
activation of MEK, ERK, and Akt. MEK and ERK promote proliferation, while Akt, which is a 
kinase, promotes survival. In mice with IQGAP1 absent, the activation of these three proteins 
was not seen. Pressure overload to the cardiomyocytes causes an increase of melusin. Melusin 
forms a complex with IQGAP1, which activates ERK. In the absence of IQGAP1, the activity of 
ERK was reduced in response to pressure, and there was an increase in cell apoptosis (Noritake 
et al. 2005; White, Erdemir, and Sacks 2012). 
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Vascular Function 
IQGAP1 is a key factor for blood vessel 
formation. IQGAP1 has a binding affinity for 
VEGF receptor 2 (VEGFR2). Blood vessel 
formation and function is affected by VEGF. 
The absence of IQGAP1 showed that VEGF-
stimulated angiogenesis was suppressed. Also, 
IQGAP1 knockout mice’s blood vessel 
formation was impaired in response to injury, 
when compared to mice possessing IQGAP1. 
Following ischemia, there is an increase in 
angiogenesis, which is caused by an increased 
expression of IQGAP1 (White, Erdemir, and 
Sacks 2012). Overexpression of IQGAP1 led to a significant increased angiogenesis in a mouse 
tumor model. This evidence shows that there is a definite correlation between the expression of 
IQGAP1 and blood vessel formation, which suggests that IQGAP1 scaffolds VEGFR2, which 
then results in the maintenance and repair of blood vessels (Hedman, Smith, and Sacks 2015). 
 
Lung Function 
The parasympathetic nervous system is 
activated by a range of factors such as 
exercise, microbes, exercise, or other 
stimuli. This activation of the 
parasympathetic nervous system eventually 
leads to the contraction of the smooth 
muscle inside the airway. This condition is 
known as asthma.  When the 
parasympathetic nervous system is 
activated, acetylcholine and histamine are 
released. Acetylcholine and histamine in turn induce Ca2+ to be released from intracellular stores 
and activate RhoA. RhoA activation leads to myosin light chain (MLC) phosphorylation. 
Phosphorylation of the myosin light chain enhances the interaction between myosin and actin, 
which in turn leads to increased muscle contraction. This process is thought to be modulated with 
IQGAP1. RhoA and p190A-RhoGAP are proteins that inactivate RhoA, which in turn means that 
the myosin light chain is not phosphorylated, so there is a decrease in the muscle cell contraction. 
IQGAP1 has been shown to immuno-precipitated with RhoA and p190A-RhoGAP. In patient 
studies, patients with lower expression of IQGAP1 in the lungs usually had asthma.(Hedman, 
Smith, and Sacks 2015). 
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IQGAP Functions Relevant to Cancer 
 
IQGAP1 has been shown to regulate a wide variety of cellular processes, which can be altered by 
manipulating the expression of IQGAP1 intracellularly. Due to the significance of the processes 
IQGAP1 regulates, it appears that IQGAP1 is imperative for maintaining normal cell function 
and homeostasis. It seems that IQGAP1 can contribute to various stages of cancer progression 
based on this. There are clear links between cancer and IQGAP. In a wide variety of cancers, 
IQGAP1 has been shown to be highly expressed. IQGAP1 is often overexpressed in cancers, 
while it has been noted that IQGAP2 expression has been decreased. The exact ways in which 
IQGAP1 contributes to cancer will be discussed in this section (White, Brown, and Sacks 2009; 
Johnson, Sharma, and Henderson 2009).  
 
 
Table 1-IQGAP1 binding partners with potential relevance to cancer (White, Brown et al. 2009). 
Cellular proliferation 
Observations of IQGAP1 in cancerous tissue has suggested that the expression level of IQGAP1 
has a direct effect with the rate of cellular proliferation. Increased proliferation of MCF7 cells 
has been shown with an overexpression of IQGAP1. This increased proliferation was determined 
Figure 14- IQGAP1 has been shown to regulate a wide variety of cellular processes, which can be altered by 
manipulating the expression of IQGAP1 intracellularly. Due to significance of the processes which IQGAP1 
regulates, it appears that IQGAP1 is imperative for maintaining normal cell function and homeostasis. This 
figure shows the percent of patients with different types of cancers with increased levels of IQGAP expression 
(https://www.proteinatlas.org/ENSG00000140575-IQGAP1/antibody#western_blot). 
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to be affected in part by the increased levels of active Rac1 and Cdc42. Proliferation stimulated 
by vascular endothelial-derived growth factor (VEGF) requires IQGAP1. Lacking IQGAP1 has 
been shown to annul VEGF stimulated proliferation in human umbilical veins, and aortic 
endothelial cells. Additionally, IQGAP1 expression has been shown to decrease in HepG2 
human hepatocellular carcinoma (HCC) cells with the use of quercetin, which is an anti-
oxidative flavonoid which possesses strong anti-proliferative properties. IQGAP1 is an important 
regulator of cellular proliferation. Neoplastic transformation is fundamentally characterized by 
uncontrolled cellular proliferation (White, Brown, and Sacks 2009; Brown and Sacks 2006) 
Cell–cell adhesion 
Metastasis of tumor cells requires cell adherence at the primary site, increased cell motility, and 
degradation of the surrounding tissue. As discussed earlier, cadherins are a large group of 
molecules that mediate cell-cell adhesion. The mechanism by which cadherins is by engaging in 
Ca2+ dependent, homophilic, trans interactions. IGQAP1 regulates cell-cell adhesion by 
interacting with beta-catenin. IQGAP1’s interaction with beta-catenin causes alpha-catenin to 
dissociate for the cadherin-catenin complex. IQGAP1 negatively inhibits cell-cell adhesion in 
this way, but IQGAP1 can also positively regulate cell-cell adhesion by interacting with Rac1 
and Cdc42. The interaction of these two proteins inhibits IQGAP1 from interacting with beta-
catenin. This positive and negative regulation of cell-cell adhesion creates a dynamic 
equilibrium. Therefore, cells can alter their cell-cell adhesion by forming these two different 
complexes. Decreased cell-cell adhesion at the primary site of the cancer leads to an increased 
chance of proteolytic degradation of the surrounding tissue (White, Brown, and Sacks 2009). 
Genetic Studies 
Genetic profiles are often compared to determine if a certain gene may be promoting the cancer. 
In order to tell if IQGAP1 is an oncogene, it’s level of expression has been compared in normal 
tissues and tumors. The level of expression between aggressive cancers and less aggressive 
cancers has also been compared to reveal if there is any correlation between a higher expression 
of the IQGAP1 gene and the particular cancer type that is being studied. Increased expression of 
IQGAP1 has been observed in several human cancers, which include lung, colorectal, and 
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oligodendroglioma. Similar results have been reported in cell lines and in mouse models (White, 
Brown, and Sacks 2009; White, Erdemir, and Sacks 2012).  
 
Table 2- How changes in IQGAP expression in neoplasms can be related to aggressive vs. less aggressive 
cancers  (White, Brown et al. 2009). 
Metastasis 
Using an in vivo scheme to show altered expression in a mouse model of melanoma, it was 
determined that IQGAP1 could have some possible role in the metastasis of these cells. Using a 
screen to show if there is any alteration of gene expression, IQGAP1 along with calmodulin and 
ERK showed a 2.5 fold increase in their expression levels in metastic cells. In the experiment 
~10,500 genes were tested for expression level. 32 of the genes showed >>2.5 fold increase in 
expression levels. 3 of the 32 genes that showed this increase in protein expression are IQGAP1 
and proteins that are known to bind with IQGAP1. Given this evidence, it is likely that the 
increase in expression of these 3 proteins promotes metastasis in some way, although more 
evidence is necessary in order to further prove this (White, Brown et al. 2009). 
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IQGAP1 and Phosphoinositide 3-Kinase (PI3K)/Akt Signaling 
 The Phosphoinositide 3-Kinase (PI3K)/Akt Signaling pathway is evolutionarily conserved from 
yeast to mammals. This pathway regulates a diverse array of cellular functions which include, 
cell growth, apoptosis, survival and metabolism (Chalhoub and Baker 2009). IQGAP1’s 
interaction with PI3Kinase is why it is important to discuss this signaling pathway. PI3Ks are 
intracellular lipid kinases that phosphorylate the 3’-hydroxyl group of phosphatidylinositols and 
phosphoinositides (Chalhoub and Baker 2009).  
The PI3K pathway is one of the most studied phosphoinositide signaling pathways. 
Phosphatidylinositol-3,4,5-trisphosphate (PIP3) is a key signaling lipid, which is synthesized in 
the PI3K pathway. PIP3 is proposed to be synthesized in a streamline matter by IQGAP1 in a 
processive manner (Choi et al. 2013). 
The synthesis of PIP3 involves three sequential steps which are undergone by phosphoinositide 
kinases. First, phosphatidylinositol 4-kinase (PI(4)K) phosphorylates phosphatidylinositol, which 
generates phosphatidylinositol-4-monophosphate (PtdIns(4)P). Phosphatidylinositol phosphate 
kinase (PIPKI) subsequently phosphorylates the product of this first reaction to generate 
phosphatidylinositol-4,5-bisphosphate (PIP2). Finally, phosphorylation of PIP2 by PI3K 
generates PIP3. Cells can generate PIP3 within seconds under acute conditions (Rameh and 
Mackey 2016; Choi et al. 2013; Choi and Anderson 2017) 
Figure 15-The PI3K pathway is a complex cellular signaling pathway which regulates a diverse array of 
cellular functions which include, cell growth, apoptosis, survival and metabolism (Chalhoub and Baker 
2009). IQGAP1’s interaction with PI3Kinase is why it is important to discuss this signaling pathway. 
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PIP2 and PIP3 have many functions within the cell, thus it is important for their concentrations 
to be regulated by this pathway. PIP2 has many functions which include regulation of: F-actin 
organization, septins, cell interaction. PIP3 functions to activate downstream signaling 
components. AKT is a protein kinase which PIP3 is most notable for activating. Activation of 
AKT kinase results in downstream anabolic signaling required for cell growth and survival 
(Rameh and Mackey 2016; Balla 2013). 
It is believed that PIP3 generation involves the de novo synthesis of PIP2. It has been 
demonstrated that PI3K uses de novo synthesized PIP2 to generate PIP3 which leads 
subsequently to Akt activation through phosphorylation by PDK1. Both, PDK1 and Akt bind 
PIP3, which leads to their co-localization (Choi et al. 2013; Choi and Anderson 2017). It has 
been theorized that since IQGAP1 is known to bind PI3K, that IQGAP1 may coordinate this 
synthesis.  
Two models have been shown for phosphoinositide signaling (Figure 16); a processive model 
and a non-processive model. a) In the processive model, it is thought that IQGAP1 might stream 
line the process of PIP3 synthesis. This model has low entropy, high efficiency, and high 
specificity. b) This non-processive model has high entropy, low efficiency and low specificity.  
This model does not make use of a scaffolding protein (Rameh and Mackey 2016; Balla 2013). 
The scaffolding properties of IQGAP1 have clearly been shown to increase agonist-stimulated 
Akt activation, both in-vivo and in-vitro (Choi et al. 2016). These findings may have direct 
relevance to cancer. This reveals ways in which PI3K driven tumor growth can be blocked 
(Rameh and Mackey 2016). 
Figure 16- Two models have been shown for phosphoinositide signaling; a processive model and a non-
processive model. a) In this processive model, it is thought that IQGAP1 might stream line the process of 
PIP3 synthesis. This model has low entropy, high efficiency, and high specificity. b) This non-processive 
model has high entropy, low efficiency and low specificity.  This model does not make use of a scaffolding 
protein (Rameh and Mackey 2016; Balla 2013). 
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Scientific Techniques 
Fluorescence Correlation Spectroscopy (FCS) 
Fluorescence correlation spectroscopy uses nanomolar concentrations of biological samples to 
detect the diffusion coefficient of fluorescently probed protein. The determination of the mobility 
related parameters of the biologically relevant molecules is the primary goal in FCS analysis. 
Changes in the diffusion coefficient of the fluorescently labeled biological molecule can be 
altered by chemical reactions, and any other phenomenon which can alter the hydrodynamic 
radius of the molecule. The diffusion coefficient in an aqueous solution is given by the Stokes-
Einstein relationship. An ideal reaction system consists of one small, labeled ligand and a large 
counterpart to create a more notable change in the diffusion coefficient of the probed molecule. 
This fluorescent technique is useful in studying protein-protein interactions as well as protein-
lipid interactions. A variety of complications must be dealt with due to the experimentation being 
done at nanomolar concentrations. Proteins often carry surface charges; thus, it is necessary to 
ensure that proteins do not adhere to any of the walls of the reaction chamber and one has to use 
specially coated chambers to ensure that this does not happen. Secondly, photophysical damage 
may also further reduce the number of detectable molecules which can influence the overall 
accuracy of the experiment. 
Fluorescence Resonance Energy Transfer (FRET) 
Fluorescence resonance energy transfer is used in this study. FRET is useful in deterring 
molecular interactions and can determine the extent of the interactions between two molecules. 
For the interaction to occur:  
• the absorption spectra of the two fluorophores must overlap. 
• fluorophore must be separated by a distance between 10-100 angstroms 
• the transition dipoles of the fluorophores must be oriented parallel to each other  
 
Figure 17- An optimum FCS reaction consists of a smaller 
probed ligand, and a large counter part to create a more notable 
change in the diffusion coefficient of the probed molecule. 
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 In this case the fluorophores are tryptophan and dansyl-PE.  Tryptophan has a maximum 
absorption wavelength of 280 nm and an emission peak that is solvatochromic. Depending on the 
polarity of the solvent the emission peak ranges from 300-350 nm. Changes in the emission 
spectra of tryptophan are due to protein-ligand binding.  The PI(4,5)P2 binding domain is 
suggested to be at the RGCT domain, which contains eight tryptophan residues. If binding occurs 
between PI(4,5)P2 and IQGAP1-C then tryptophan will quench the fluorescence of dansyl-PE 
Binding will lead to a decrease in Tryptophan emission (300-400nm) and increase dansyl-PE 
emission (450-600nm).  
 
 
Circular Dichroism 
Circular dichroism (CD) is particularly good for characterizing the 
secondary structure of a protein. Using the far UV spectral region (190-
250 nm), CD can measure the structural asymmetry of a protein by 
measuring the differences in the absorption of left-handed polarized 
light versus right handed polarized light. It is possible to have zero CD 
intensity if there is no regular structure. Ordered structures will show a 
spectrum of both positive and negative signals. At wavelength between 
190-250 nm, the peptide bond is the chromophore. When the peptide 
bond is located in regular, folded environments, a signal will arise 
(“Circular Dichroism” n.d.). 
Secondary structures such as alpha-helix, beta-sheet, and random coil 
each give a characteristic CD spectrum, which is illustrated in Figure 
17. CD reflects the average structure of the molecule. For example, if 
40% of the protein was beta-sheet, then you would only be able to tell 
the average of the protein, not which specific residues are involved 
(“Circular Dichroism” n.d.). 
Optimum CD experiments require solutions containing 1 mg/mL to 50 
μg/ml of protein, in a solution which does not have high absorbance in 
the Far UV range. 
  
Figure 18- FRET between tryptophan and dansyl-PE will occur if there is 
binding between IQGAP1-C and PIP2. 
Figure 19- Secondary structures such as 
alpha-helix, beta-sheet, and random coil 
each give a charactersitc CD spectrum 
(“Circular Dichroism” n.d.). 
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Proposed Research and Aims 
Aims 
Aim 1- Purify full length IQGAP1 protein as well as IQGAP1 domains 
 
 
Figure 20- IQGAP1 full length protein and mutants containing different domains of IQGAP1. 
In order to perform binding experiments which will help to determine the exact mechanism by 
which IQGAP binds membranes, it will be necessary to purify full length IQGAP1 proteins as 
well as IQGAP1 domains. The domains that will be purified can be seen in Figure 20. In total 
there are 9 different IQGAP1 domains that will need to be purified. Once these domains are 
purified, binding studies can be done. 
Aim 2- Characterize the binding between IQGAP1 and PIP2 and PIP3 using LUVs 
In order to characterize the binding between IQGAP1 and PIP2 and PIP3, the IQGAP full length 
protein and its individual domains must be purified. Once purified binding experiments will be 
done with the use of large unilamellar vesicles (LUVs). The key to having accurate data for this 
part of the experiment will be to make sure that the LUVs are of uniform size and composition 
and that the protein is pure. By testing experimentally the binding affinity for PIP2 and PIP3, we 
will be able to experimentally prove or disprove the proposed mechanism for IQGAP1 as seen in 
Figure 1. 
Research Outline 
Aim 1- Purify full length IQGAP1 protein as well as IQGAP1 domains 
Purifying full length IQGAP1 protein as well as IQGAP1 domains will be a key part of this 
research. In order to perform binding experiments, which will produce accurate results, this 
protein must be purified in a way that preserves its function and does not truncate the full-length 
protein. It will also be important to ensure that there is a good yield of the protein and that the 
purification yields a pure protein with minimal contaminants. 
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We will use a few different methods in the purification process: 
• Adjustment of buffering agents 
• Protein purification by use of the Batch Method 
• Fast Protein Liquid Chromatography (FPLC) 
 
Protein Purification can then be analyzed using a few different methods: 
• Mass Spectrometry 
• Gel Electrophoresis 
• Bradford Protein Assay 
Purification Process 
Adjustment of Buffering Agents 
The pH and salt concentration of buffering agents can be adjusted in order to ensure that the 
different domains will stay solubilized. Buffering agents will have their pH altered when 
purifying the different IQGAP1 domains because of the different isoelectric points of each of the 
domains. 
Protein purification by use of the Batch Method: GST-N Beads and Glutathione Elution 
Glutathione superflow agarose enables the high-purity purification of GST fusion proteins. The 
agarose is compatible with a wide range of chemicals and at a range of pH values. It is also 
reusable, relatively simple and quick to purify proteins. This method entails adding the protein 
extract to a bed of beads and allowing the beads to bind to the protein. Once the beads are bound 
to the protein of interest, multiple washes can be done to wash away impurities. Once enough 
washes have been done, the protein can be eluted by adding Glutathione. The protein extract can 
then be checked for purity using gel electrophoresis, and a Bradford protein assay. 
Protein yield and purity are dependent upon expression level, conformation, and solubility 
characteristics of the recombinant fusion protein, as well as buffer conditions. In order to 
optimize the yield and purity using this method, buffers will have to be altered in order to keep 
the protein of interest solubilized. 
Fast Protein Liquid Chromatography (FPLC) 
This purification method is similar to that of the Batch Method. The protein of interest in the 
purification is fused with a GST tag. The protein then enters the column and binds to the 
stationary phase. Once bound to the stationary phase, impurities are washed away as in the Batch 
Method. In order to elute the protein, an elution buffer must be used which will cause the protein 
to lose its binding affinity to the stationary phase. Samples are collected, and the Bradford 
protein assay can be used to determine which sample contains the highest concentration of 
sample. This method is similar to that of a gravity Liquid chromatography set up, but it is easier 
to visualize if the protein is eluted from the column because a graph is created for the run on the 
computer. Another differentiator to that of standard liquid chromatography is the ability to 
quickly and easily change buffers and monitor the salt concentration of the run. This method is 
slightly more complicated to that of the Batch method. For initial purification process it might be 
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easier to first use the Batch method due to its simplicity, and then determine if it will be 
necessary to then use FPLC. 
Analysis of Protein Purification Process 
Once the purification process is complete, before binding studies can be done using the protein, 
the protein purification must be analyzed to ensure that the protein of interest has indeed been 
purified, and the concentration of the protein that was purified must be determined. The analysis 
will be done using a few different methods. During initial purification steps, when a new method 
of protein purification has been used, Mass Spec must be used in order to show that we are 
indeed purifying the protein of interest and that we are not inadvertently purifying a different 
protein. Once it has been determined that the protein of interest is being purified, the purification 
can be analyzed by SDS-PAGE. This will determine if there are impurities found in the 
purification and also if the protein is being truncated during the purification process. 
Densiometric analysis of the bands using Image J can also be used to determine the 
concentration of protein. Bradford Protein assay can also be used to determine the protein 
concentration of the purification 
Aim 2- Characterize the binding between IQGAP1 and PIP2 and PIP3 using LUVs 
Large unilamellar vesicles (LUVs) are lipid vesicles. These vesicles can be formed 
experimentally and used for binding experiments. By experimentally producing these vesicles 
with PIP2 and PIP3 as part of the composition of the vesicle, we 
will be able to test the binding affinity of PIP2 and PIP3 to the full 
length IQGAP1 protein as well as the individual domains. Part of 
the experiment will include producing these LUVs and 
determining whether they are of a uniform size. The actual 
binding experiment entails adding LUVs labeled with dansyl-PE 
to the protein of interest and using fluorescence spectroscopy to 
determine if there is a change in Trp fluorescence emission 
intensity. Measuring the diffusion coefficient using FCS will also 
help to determine if binding is occurring or not. Initially we would expect the protein to have a 
higher diffusion coefficient, but if binding is occurring between the LUVs and the protein, then 
the diffusion coefficient should decrease, which would indicate that there is a binding. 
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Methodology 
Protein Expression 
A single colony of BL21DE3 E.coli cells containing either IQGAP1 or IQGAP1-C was 
inoculated into 100mL of LB broth containing 150mg/mL ampicillin and placed in the shaker 
(250rpm, 37°C) overnight to grow. 10 mL of starter culture was added to a flask containing 
900mL LB, 150mg/mL ampicillin and 100uL of antifoaming agent. The flask was placed into the 
shaker (250rpm, 37°C) and incubated until it reached an OD of 0.6. Once the measured OD was 
at ~0.6, the culture was induced with 1 mM IPTG and incubated in the shaker overnight 
(250rpm, 37°C). The cell culture was centrifuged at 8,000 x g for 10 minutes at 4°C. The 
supernatant was discarded, and the pellets were stored in -20°C.   
Protein Purification 
Two different methods were used to purify IQGAP1 and IQGAP1C. These methods include the 
Batch Method and Fast Protein Liquid Chromatography (FPLC). 
Batch Method 
The pelleted cell culture was obtained and thawed on ice. Next, the cell pellet was resuspended 
in 2X volume Equilibration Buffer (20 mL) and a Roche Tablet was added in order to minimize 
degradation by proteases. Once the cell pellet is homogenized, cells were lysed by sonication at 
5mW. The sonication process consisted of sonicating on ice for 20s and 20s off four times. 
Following this step, cells were centrifuged at 18,000 x g for 30 min at 4C. Supernatant was 
collected, and a small sample was kept for future analysis. 1 mL of Glutathione Superflow 
Agarose was added to a 15mL centrifuge tube along with 5 mL of equilibration buffer. Agarose 
was centrifuged for 2 minutes at 700 x g and the supernatant was carefully removed and 
discarded. This process was then repeated once more. 12 mL of prepared protein extract was 
added to the Glutathione Superflow Agarose and was mixed with an end-over-end rotary mixer 
overnight. Next, this mixture was centrifuged at 700 x g for 2 minutes and then the supernatant 
was removed. 100 uL of the supernatant was saved for analysis. The agarose was washed three 
times with 5 mL of equilibration buffer. GST-tagged proteins were eluted by resuspending resin 
bed in 1 mL of the first Elution buffer (10mM L-Glutathione) and mixing in a end-over-end 
rotary mixer for 10 minutes followed by centrifugation at 700 x g for 2 minutes. Supernatant was 
removed and saved. This step was then repeated with elution buffer 2 (30mM L-Glutathione). 
Protein was stored at 4°C.  
Fast Protein Liquid Chromatography (FPLC) 
The pelleted cell culture was obtained and thawed on ice. Next, the cell pellet was resuspended 
in 2X volume Equilibration Buffer (100mM NaCl, 50 mM HEPES, 0.1 mM EDTA) (20 mL) and 
a Roche Tablet (protease inhibitor) was added to minimize degradation by proteases. Once the 
cell pellet is homogenized, cells were lysed by sonication at 5mW. The sonication process 
consisted of sonicating on ice for 20s and 20s off four times. Following this step, cells were 
centrifuged at 18,000 x g for 30 min at 4C. Supernatant was collected, and a small fraction was 
kept for future analysis. The supernatant was then filtered with a 20 nm filter to ensure that the 
column would not get blocked. 
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The column was prepared by first purging the system with deionized water and equilibration 
buffer (100mM NaCl, 50 mM HEPES, 0.1 mM EDTA). Next, the Protino GST/4B column was 
inserted and 15 mL of Equilibration Buffer until a baseline absorbance was reached. After, 20 
mL of the protein supernatant was inserted into the Column at a rate of 0.25 mL/min. Following 
this, the column was washed with 20 mL of equilibration buffer at a rate of 1.0 mL/min. Next the 
column was washed with 20 mL ATP buffer (20 mL equilibration buffer, 0.4mL MgSO4, 60 mg 
ATP) at a rate of 1.0 mL/min. Following this an additional 10 mL wash with equilibration buffer 
was done. The elution step consisted of 30 mL of a linear gradient of the elution buffer (50mM 
Tris base, 10 mM Glutathione) at a rate of 0.75 mL/min. 0.5 mL samples were collected during 
the elution step and then analyzed for purity and concentration. During the elution step the 
conductivity decreased significantly before the protein eluted. Samples were taken when the UV 
absorption increased.  
Purity Assessment, Quantification of Protein Concentration, and Storage 
A 10% denaturing SDS-PAGE gel was run with 20uL of sample and 5uL of 5x SDS running 
buffer. The gels were stained with Fairbanks A staining (25% isopropanol, 10% acetic acid, 
0.05% Coomassie R) and de-stained with Fairbanks D (10% acetic acid solution). The gel bands 
were visually assessed to determine the purity of the protein of interest, and then imaged for 
future reference. 
Western Blot was then done to ensure that the correct protein was purified. A 10% denaturing 
SDS-PAGE gel was run with 20uL of sample and 5uL of 5x SDS running buffer. Sample was 
then transferred to nitrocellulose membrane at 60V for 4 hours. Membrane was then blocked 
with 1% Milk for 1 hour at 40°C. Following this, the membrane was incubated with the primary 
antibody, IQGAP1 Rabbit, for 1 hour. To prepare the primary antibody, 5 μL of antibody was 
diluted in 5 mL of 0.1%TBST. After applying the antibody, the membrane was washed with 15 
mL of 0.1%TBST. The secondary antibody, anti-rabbit goat IgG, was incubated with the 
membrane for 10 minutes. The secondary antibody was prepared by adding 5 μL of the antibody 
to 5 mL of 0.1%TBST. The membrane was then washed with 15 mL of 0.1% TBST (4X). 
ClarityTM Western ECL Substrate (2 mL) was used develop the membrane, and a Bio-Rad 
Chemi-Doc XRS+ scanner was used. 
Quantification of protein concentration was determined using the Bradford method. First, a BSA 
standard curve was created. A dilution series of 0.2 mg/mL BSA stock (in Bradford reagent) 
over 11 wells on a 96 well plate was done to yield a final volume of 100μL Dilutions ranged 
from 1:10 to 1:100. The wells were incubated at room temperature and then tested for 
absorbance at 600nm. A 10 and 20-fold dilution of protein samples were prepared and then the 
protein concentration was calculated based on the BSA standard curve. Each run was done in 
triplicate and blanked with the same mixture not containing enzyme. 
For short term storage the protein was stored at 40°C. For longer term storage, the protein was 
diluted 1:1 with glycerol and then stored at -80°C. 
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Model Membrane Binding Studies  
Spectrometer Settings 
A Photon Technology International (PTI) spectrophotometer was used for this study. The 
excitation wavelength was set to 280nm since Tryptophan typically has a maximum absorption 
wavelength of 280 nm. The emission wavelength was scanned from 300-600nm. The scan speed 
was set to 150 Hz. Three averages were taken to minimize the noise of the data. Voltage was 
adjusted so that the emission peaks would not exceed intensity of 4000 units. 
Sample Preparation 
50μL of sample (1.0μg/μL) was prepared in a low volume quartz cuvette (100 μL) with a path 
length of 3.00mm. the protein was dissolved in 100mM NaCl, 50 mM HEPES, 0.1 mM EDTA 
buffer. 
Large Unilamellar Vesicles (LUVs) Preparation 
Large unilamellar vesicles are obtained by extrusion of multilamellar vesicles through a 
polycarbonate filter with the pore size of the filter being equal to the desired diameter of the 
unilamellar vesicles. Multilamellar vesicles were prepared by first determining the composition 
of the vesicles. Once the composition was determined the lipids were dissolved in chloroform 
(CHCl3) in a sample vial. Fractional precipitation of the lipids was minimized by rapidly 
evaporating the solvent with a stream of nitrogen gas. Samples were then stored at ~80°C in a 
vacuum (25mmHg) overnight to remove any remaining traces of organic solvent. Once dried, the 
dried lipid mixture was resuspended in a buffer solution (100mM NaCl, 50 mM HEPES, 0.1 mM 
EDTA) and “vortexed.” 
Large unilamellar vesicles are then obtained by the extrusion of multilamellar vesicles. An 
extrusion kit from Avanti Polar Lipids was used. A 100nm pore size filter was used, and the 
vesicle suspension is moved multiple times through the filter to obtain a narrow size distribution. 
The vesicle size distribution was determined by using a dynamic light scattering (DLS) 
instrument and Zetasizer software. Samples (~ 200 μL) were measured at 20°C with a Quartz 
cuvette (3.00mm pathlength). If multiple size distributions of vesicles appear, then further 
extrusion is necessary. Once a narrow size distribution was created, then the vesicles are suitable 
for binding studies.  
Lipid Titrations 
Lipid vesicles were titrated in 1μL and 5μL increments. 
Circular Dichroism 
Protein sample was dialyzed in the MOPS buffer (20mM Sodium Phosphate, 100mM NaCl) 
using us 0.1-0.5 5,000MWCO Slide-A-Lyzer® dialysis cassettes. The sample was then measured 
with the circular dichroism spectrometer between 190-300 nm. 
Fluorescence Correlation Spectroscopy (FCS) 
Sample Preparation 
50μL of sample was prepared in a low volume quartz cuvette (100 μL) with a path length of 
3.00mm. Protein was in 100mM NaCl, 50 mM HEPES, 0.1 mM EDTA buffer 
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Fluorescent Labeling  
Purified IQGAP1 and IQGAP1-C in 100mM NaCl, 50 mM HEPES, 0.1 mM EDTA were labeled 
overnight at 4°C with AlexaFluor488 C5 Maleimide Dye. The dye was subsequently quenched 
with beta-mercaptoethanol for 20 minutes. Unlabeled dye was removed by dialysis using the 500 
μL  Vivaspin dialysis device. The NanoDrop was used to assess the degree of protein 
concentration and free dye. Samples were then stored on ice. 
Large Unilamellar Vesicles (LUVs) Preparation 
Lipids were prepared identically to the method used above. Lipid concentration was 30 μM, and 
the experiment was repeated five times for accuracy. 
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Results and Discussion 
Immuno-colocalization 
 
One of the more common applications of fluorescence microscopy is to compare the subcellular 
distribution of two fluorescently labelled molecules (Melo, Prieto, and Coutinho 2014). In the 
case of this study, there are two comparisons being made. GFP-PIPKIγ α87 and mCherry-labeled 
PH PLCδ1. Another colocalization study that was carried out was between IQGAP1 and PIPKIγ 
α87. Previous studies have suggested IQGAP1 and PIPKIγ α87 association. This method is not 
appropriate for detecting molecular interactions. The resolution of light microscopes is not 
sufficient to identify the physical apposition of two molecules. In order to be certain of molecular 
interactions, higher resolution studies such as fluorescence resonance energy transfer have to be 
employed. 
In this study we see co-localization occurring between overexpressed GFP-PIPKIγ α87 and 
mCherry-labeled PH PLCδ1, a sensor for PI(4,5)P2. Strong co-localization is also seen between 
eGFP-IQGAP1 and PH PLCδ1. Co-localization between PIPKIγ α87, PH PLCδ1, and IQGAP1, 
PH PLCδ1 is quantified using Pearson’s coefficient. Pearson correlation coefficient values range 
from 1 to -1. PCC values are 1 for two images when fluorescence intensities are linearly related. 
PCC values of -1 are observed for two images where the fluorescence intensities are inversely, 
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but perfectly related. Values which are near zero reflect probes whose distributions are unrelated 
to each other. According to the PCC values which were obtained for this study, GFP-PIPKIγ α87 
and mCherry-labeled PH PLCδ1, a sensor for PI(4,5)P2, shows a stronger correlation, while 
eGFP-IQGAP1 and PH PLCδ1 interaction is associated with a value of ~0.28 . This data 
suggests that there is a correlation between eGFP-IQGAP1 and PH PLCδ1, but further studies 
will be necessary. For this reason, it will be necessary to further prove that the suggested 
association between eGFP-IQGAP1 and PH PLCδ1 from immune-colocalization experiments is 
indeed due to molecular interactions. This will be proved with purification of IQGAP1 and with 
fluorescence resonance energy transfer with the use of model membranes and partially with FCS. 
Protein Purification 
Two methods were used to purify IQGAP1 and IQGAP1-C. These methods were the Batch 
method and Fast Protein Liquid Chromatography. These two methods were similar in they both 
made use of the GST fusion tag on IQGAP1 and IQGAP1-C. Additional information on further 
troubleshooting will be included in the Appendix. 
Batch Method 
Initial attempts of the purification of IQGAP1 and IQGAP1-C were done using the Batch method 
due to its simplicity. The Batch method involves using stationary glutathione, which will bind to 
the GST fusion tag on the IQGAP1 and IQGAP1-C Protein. Also, due to initial trials of the 
purification process leading to insoluble aggregates, this would have led to issues blocking the 
column on an FPLC machine. There were a few issues that were encountered when first 
purifying the protein which included no/low protein expression, degradation, formation of 
insoluble aggregates.  
Figure 21- Pearson’s correlation coefficient for eGFP-IQGAP1 and 
PH PLCδ1, and GFP-PIPKIγ α87 and mCherry-labeled PH PLCδ1, 
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The first purification of IQGAP1-C showed (Figure 22) that there was no sign of any bands for 
the two elution steps. It was determined that the glutathione (GSH) was old, and this was likely 
the cause of the lack of bands. After acquiring new GSH for the elution buffer, IQGAP1-C was 
able to be purified (Figure 23), but a significant amount of degradation was present, which didn’t 
make this suitable for further characterization studies. 
Due to the formation of insoluble aggregates and the significant amount of degradation found 
using this method, it was determined that using an FPLC may be more successful. 
 
 
Figure 22-Purification of IQGAP1-C with the use of the Batch Method. Lane 1 is a protein 
standard, Lane 2 is the lysate, Lanes 3 and 4 are washes, and Lanes 5 and 6 are elution samples. 
This figure is an example of one of this first issues when encountered while purifying IQGAP1, 
which was no/ low protein expression. 
Figure 23- This SDS PAGE Gel shows another purification of IQGAP1-C using the Batch method. IQGAP1-
C is ~120kDA with the GST- Fusion tag. The 10% SDS PAGE gel confirms that protein is present in the two 
elution steps, but there is a significant degradation present. 
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Fast Protein Liquid Chromatography 
Many issues were encountered when purifying IQGAP1, which are further discussed in the 
Appendix. An overview of some of the issues encountered and how they were resolved include 
poor protein expression, high-degree of degradation, and poor binding of protein to the GST 
column. Poor protein expression was found early on in the project. It was determined that this 
could have been due to some sort of contamination present in the reagents, which was causing 
there to be a lack of expression. It was also hypothesized that this could have been to due the  
IPTG stocks. In order to combat these problems, new reagents were ordered and fresh IPTG 
stocks were made. These steps helped to fix this problem, although there was still an issue with 
there being excessive degradation. One way in which this problem was alleviated was through 
lowering the induction temperature to 18°C and then expressing overnight. Initially, expression 
was tried at both 37°C and 18°C and it was determined that overnight expression at the lower 
temperature led to less formation of insoluble aggregates, and overall less degradation. Another 
way in which the degradation was minimized was through optimizing the sonication time. Poor 
binding of IQGAP1-C to the GST column was also observed. To fix this issue, the rate of sample 
loading was reduced from 0.75 mL/min to 0.25 mL/min, which improved the concentration of 
protein collected. With the purification of this domain of IQGAP1 and the quantification of 
purity with Bradford protein assay and western blot, further characterization studies could now 
be undergone which included; circular dichroism, fluorescence correlation spectroscopy, 
fluorescence resonance energy transfer studies. 
 
 
 
Figure 24-For this study the optimum 
parameters for purifying the protein were that 
washes were done at 1mL/min, Sample Loading 
was done at 0.25 mL/min, and Elution Steps 
were done at 0.75 mL/min. A small peak can be 
seen during the elution step indicating that the 
protein has bond to the GSH in solution and has 
lost its affinity for the column. 
Figure 25- Gel of successful purification of IQGAP1-C. 
IQGAP1-C can be found at approximately 120 kDa. 
There is no sign of degradation, as there are no smaller 
bands found. 
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Circular Dichroism 
Analysis from circular dichroism reveal an estimate of the secondary structure of IQGAP1-C: 
45% helices, 2% antiparallel, 3%, 4% turns, and 46% other. Helices consisted of 23% regular 
and 21% distorted helices. Antiparallel structures consisted of 2% left twisted and 0.2% right 
twisted. The RMSD and NRMSD were 1.0002 and 0.0691 respectively. This data is important in 
that IQGAP1-Cs structure must be further characterized to help to better determine the exact way 
in which it scaffolds other proteins. 
 
Fluorescence Correlation Spectroscopy (FCS) 
Using fluorescence correlation spectroscopy, we were able to further prove the binding between 
IQGAP1 and IQGAP1-C with PI(4,5)P2. As discussed early in the background section, FCS was 
used to measure the diffusion coefficient of the fluorescently probed molecule, which in this case 
is IQGAP1 and IQGAP1-C. Once probes were attached to IQGAP1 and IQGAP1-C, it was 
important to do a control experiment with 100% PC lipid vesicles. 
Values for control experiments and for lipid vesicles containing 5% PI(4,5)P2, can be found in 
Table 3 and Table 4. As can be seen in the two tables, the diffusion coefficients for both 
IQGAP1 and IQGAP1-C are around 330 um2/s with the control vesicles. Upon the addition of 
vesicles containing 5% PI(4,5)P2, the diffusion coefficient decreases significantly, suggesting 
that there is some sort of binding occurring. This change in the diffusion coefficient is due to 
ligand binding affecting the size and also possibly the hydrodynamic radius of the fluorescently 
probed protein.  
Figure 26- Analysis from circular dichroism reveal that the structure of IQGAP1-C 
consists of 45% helices, 2% antiparallel, 3%, 4% turns, and 46% other. 
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Table 3- Diffusion Coefficients for IQGAP1 experiments with 100%PC vesicles and PI(4,5)P2. 
 
Table 4- Diffusion Coefficients for IQGAP1-C experiments with 100%PC vesicles and PI(4,5)P2. 
 
Although the FCS data suggests that there is some sort of binding occurring between IQGAP1 
and IQGAP1-C, the data was very-noisy, and the standard deviation was very high which doesn’t 
make this data very suitable to be used to prove binding. This high degree of inaccuracy could 
have been due to a variety of factors. First, due to the surface charge of proteins, they may have 
adhered to cover slips or to the measuring chamber, which is why for future experimentation 
with this technique, it would be important to use a chamber that would limit this. Also, due to the 
nature of FCS and two-photon excitation, photophysical damage may have reduced the number 
of detected molecules. Overall, this could have led to the high degree of inaccuracy which was 
observed using this technique. 
However, this technique could be useful in the future to study any conformational changes that 
might occur with PI(4,5)P2 binding. Figure 27 shows a proposed mechanism in which IQGAP1 
changes from an inhibited state to a fully open state. This proposed mechanism suggests that 
IQGAP1 changes from the partially open state, into a fully open state due to Cdc 42 and Rac1 
binding on the GRD domain. Another proposition is that binding of PI(4,5)P2 on the RGCT 
domain will also lead to IQGAP1 fully opening. The reason why FCS studies would be able to 
effectively measure these conformational changes is that the three-dimensional structure 
influences the mobility, or diffusion coefficient, of the molecule. Thus if PI(4,5)P2 is causing this 
conformational change then there would be a large decrease in the diffusion coefficient. IQGAP1 
is much larger than the PI(4,5)P2 vesicle, so if the protein is fluorescently labelled, then any 
significant changes would be due to changes in the conformation of IQGAP1. Alternatively, to 
measure the binding of PI(4,5)P2, it would be better to fluorescently label PI(4,5)P2. PI(4,5)P2 
vesicles are very small, and if there is binding occurring between IQGAP1 and the vesicles, then 
any significant change in the diffusion coefficient of PI(4,5)P2 vesicles would be due to IQGAP1 
or IQGAP1-C binding. 
 
 
IQGAP1
Parameter 1 2 3 4 5 Average Standard Deviation
D um^2/s  (100% PC) 274 354 319 347 379 334.6 35.82513084
D um^2/s (5% PIP2, 30%PS and 65%PC) 173 146 125 182 151 155.4 20.24450543
IQGAP1C
Parameter 1 2 3 4 5 Average Standard Deviation
D um^2/s  (100% PC) 341 383 296 360 255 327 45.96955514
D um^2/s (5% PIP2, 30%PS and 65%PC) 128 233 206 189 44.51965858
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Model Membrane Binding Study 
Similar to FCS, FRET relies on two fluorophores: a donor and an acceptor. In the case of this 
experiment, it was not necessary to fluorescently tag the protein, but instead the donor 
fluorophore would be tryptophan. IQGAP1-C contains eight tryptophan residues in the RGCT 
domain where binding is proposed to occur. Dansyl-PE would therefore be the acceptor. 
 
Like the FCS experiment, the model membrane study required the use of a lipids of three varying 
compositions: 
• 98% PC, 2%dPE vesicles were used as a control group. 
• 93% PC, 2%dPE, 5% PI(4,5)P2 
• 65% PC, 30% PS, 5% PI(4,5)P2, 2%dPE  
 The control group, 98%PC and 2% d-PE, would ensure that any binding occurring between the 
lipid vesicles containing 5% PI(4,5)P2 would be due to binding. Phosphatidylcholine (PC) adds 
an additional positively charged group, choline, to the head group. Thus, any binding between 
the control group and IQGAP1-C would be due to electrostatics. Binding with the second group 
of model membranes, 93% PC, 2%dPE, 5% PI(4,5)P2, would either be due to a combination of 
electrostatics and/or binding between PI(4,5)P2 and IQGAP1-C. The third group, 65% PC, 30% 
Figure 27-Proposed mechanism suggests that phosphorylation at Serine 1443 relieves N- and C- termini 
interactions which in turn leads to the partial opening of the protein. This partial opening in turn allows 
PIPKI access to the binding site of the IQ domain. It is then theorized that either binding of Cdc42 and Rac1 
on the GRD domain or binding of PI4,5P2 on the RGCT domain fully opens the structure. 
 
Figure 28- Tryptophan has a maximum absorption 
wavelength of 280 nm and an emission peak that is 
solvatochromic. Depending on the polarity of the 
solvent the emission peak ranges from 300-350 nm. 
The fluorescence emission of tryptophan is 
quenched by dansyl-PE, which has a maximum 
absorption wavelength at 336 nm. 
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PS, 5% PI(4,5)P2, 2%dPE, utilizes phosphatidylserine (PS), which is composed of a negatively 
charged phosphate group attached to serine at the hydroxyl end. At physiological pH, the 
carboxyl group will have a charge of -1, which is useful for this experiment. Due to proteins 
usually carrying surface charges, it is necessary to rule out any binding that might be occurring 
between the vesicles and IQGAP1-C due to electrostatics. PS is negatively charged, which 
means there will be some repulsion between the vesicles. Any binding that is occurring between  
PI(4,5)P2 and IQGAP1-C would be due to binding, instead of electrostatic interactions. 
 
If binding is occuring between IQGAP1-C and PI(4,5)P2 then the tryptophan emission peak 
should decrease as it is quenched by dansyl-PE, which has a maximum absorption wavelength at 
approximately tryptophan’s maximum emission peak (336 nm). The dansyl emission peak 
should increase due to tryptophan donating fluorescence. Dansyl fluorescence will also increase 
due to the titration of lipid vesicles, which is increasing the concentration of dansyl-PE. Results 
are then normalized for dilution. Normalized results for the binding experiments are shown 
below: 
 
 
 
Figure 29- 98% PC, 2%dPE were used as a control group to ensure no electrostatic interactions were 
taking place between IQGAP1-C and the lipid vesicle. Between 300-400nm there is little change in the 
tryptophan emission peak, meaning it is not being quenched by dansyl-PE. This indicates that there is 
little to no interaction between the control group and IQGAP1-C 
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As shown in the figures above: The 93% PC, 2%dPE, 5% PI(4,5)P2 lipid composition shows a 
decrease in the tryptophan emission peak as there is a higher concentration of lipid vesicles. This 
indicates that there is some sort of binding occurring between PI(4,5)P2 and IQGAP1-C. As the 
tryptophan emission peak is quenched, the dansyl emission peak significantly increases. The 
65% PC, 30% PS, 5% PI(4,5)P2, 2%dPE lipid composition was used to rule out any electrostatic 
interactions that might have been occurring. Similarly, to Figure 32, shows a decrease in the 
Figure 30- The 93% PC, 2%dPE, 5% PI(4,5)P2 lipid composition shows a decrease in the tryptophan 
emission peak as there is a higher concentration of lipid vesicles. This indicates that there is some sort of 
binding occurring between PI(4,5)P2 and IQGAP1-C. As the tryptophan emission peak is quenched, the 
dansyl emission peak significantly increases. 
Figure 31-The 65% PC, 30% PS, 5% PI(4,5)P2, 2%dPE lipid composition was used to rule out any 
electrostatic interactions that might have been occurring. Similarly, to Figure 32, shows a decrease in the 
tryptophan emission peak as there is a higher concentration of lipid vesicles. This indicates that there is 
some sort of binding occurring between PI(4,5)P2 and IQGAP1-C. As the tryptophan emission peak is 
quenched, the dansyl emission peak significantly increases. 
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tryptophan emission peak as there is a higher concentration of lipid vesicles. This indicates that 
there is some sort of binding occurring between PI(4,5)P2 and IQGAP1-C. As the tryptophan 
emission peak is quenched, the dansyl emission peak significantly increases. 
This data was then averaged, and the lipid concentration were calculated to in order to calculate 
the equilibrium dissociation constant (Kd). The absorption peak of tryptophan for each titration 
interval was taken and then averaged from the three trials for each lipid composition. This can be 
seen in the figure below:  
 
From the binding curve above, the Kd’s were calculated to be 108+/-60 μM for vesicles 
containing PS, and 225  +/-100 μM for vesicles containing 93% PC, 2%dPE, 5% PI(4,5)P2. 
Once again the increased Kd for vesicles lacking PS is most liekly due to electrostatic 
interactions between the lipids and the protein. While the decreaed Kd for vesicles containing PS 
Figure 32- Tryptophan has an absorption peak at ~335 nm. Each lipid composition was titrated in triplicate and 
the peak at 335 nm was taken. 98% PC, 2%dPE vesicles showed no binding according to this binding curve. 
93% PC, 2%dPE, 5% PI(4,5)P2 vesicles showed weak binding. 65% PC, 30% PS, 5% PI(4,5)P2, 2%dPE 
showed weaker binding than the previous lipid composition most likely due to less electrostatic interactions. 
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is due to the negative charge that this lipid carries at physiological pH. Electrostatic repulsion 
will occur between the negative surface charge of the protein and the negative charge of PS. 
This data further proves the model in which PI(4,5)P2 directly binds to IQGAP1’s RGCT 
domain.  Although this method was used to prove that there is some weak interaction between 
PI(4,5)P2 and IQGAP1-C, this method does not prove what causes IQGAP1 to go from the 
inhibited to partially-open to fully-open state. 
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Conclusions and Future Directions 
 
From the experimental data, it is confirmed that PIP2 weakly binds to IQGAP1-C. This confirms 
that the C-terminus domain of IQGAP1-C contains the PIP2 binding domain. This also confirms 
the model suggested in the introduction, stating that either binding of PIP2 to the RGCT domain 
of IQGAP1 or binding of Cdc 42 and Rac1 to the GRD domain causes IQGAP1 to move from 
the partially open state to the open state.  
 
PIP2 binding to IQGAP1-C was confirmed through several ways. First by using immuno-
colocalization studies, Strong co-localization is also seen between eGFP-IQGAP1 and PH 
PLCδ1, a sensor for PI(4,5)P2. Using Pearson’s Correlation Coefficient this association is able to 
be quantified. This data alone is not sufficient in proving the binding between PIP2 and 
IQGAP1-C, furhter fluoresence studies were needed. FCS was subsequently used to further 
prove the binding between IQGAP1-C and PIP2. Using diffusional analysis with the FCS 
measurments, it was determined that the addition of PIP2 to  fluoresently probed IQGAP1 and 
IQGAP1-C caused a change in the diffusion coefficent. This change in the diffusion coefficent 
can suggest a few different things. First, binding of PIP2 would affect increase the size of 
IQGAP1 which was subsequently cause a change in diffusion coefficent. Secondly, binding of 
PIP2 could alter the conformation of IQGAP1, as discussed in Figure 1, and therfore also cause a 
change in the diffusion coefficient. This data may suggest what is occuring, but due to a high 
degree of inaccuracy it was necessary to use other methods. FRET studies were then used to 
produce more accurate data which proved the weak binding between IQGAP1 and PIP2, but 
along with the information from immuno-colalization it was determined that in-vivo, there may 
be other proteins involved that cause IQGAP1 to have stronger binding. 
 
Determing the exact way in which IQGAP1 alters conformation from the inhibited to partially 
open to open state will require future studies. It will be important to express and purify the other 
domains of IQGAP1 shown in Figure 20. This will allow characterization of each of the 
individual domains to help unlock the structure and the way in which IQGAP1 works. Further 
characterization of the binding between IQGAP1 and other IQGAP1 domains with PIP2 and 
PIP3 in vitro is all necessary. Also it will be necessary to characterize the effects of purified 
PIPK1 on IQGAP1-PIP2 binding. Due to immuno-colocalization studeis suggesting that 
IQGAP1 and PIP2 have a higher degree of association in-vivo, it will be necessary to determine 
additional molecules which may enhance binding between IQGAP1 and PIP2. Further FCS and 
FRET studies with IQGAP1 domain will help to further prove the model of IQGAP1 
conformatuional change. 
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Appendix 
Protein Purification 
Fast Protein Liquid Chromatography 
 
 
  
 
 
 
Figure 34- Initial FPLC runs showed high degrees of degradation when 
attempting to purify full length IQGAP1. Due to time constraints IQGAP1-C 
was chosen to be purified due to its smaller size. 
Figure 33-Native Gel of IQGAP1 and IQGAP1-C purified using 
FPLC. There is significant degradation in both proteins. 
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Figure 35- Excessive degradation was observed when 
purifying IQGAP1-C. It was determined that this degradation 
was due to a combination of excessive sonication and sub-
optimal induction conditions. 
Figure 36- The protein sample from Figure 36 was 
concentrated using a 5,000 mW filter to attempt to remove 
the smaller degraded proteins. This was unsuccessful in that 
the degraded protein was concentrated.  
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Figure 37-This Figure shows an image from the FPLC displaying the UV absorbtion. The sample loading 
step was done at too high of a rate, which did not allow IQGAP1-C to bind to the column. This resulted in 
a lack of protein in 10% SDS Gel. 
Figure 38- A slower rate was used for the sample loading step in the FPLC 
purification process, which led to a bigger elution peak. Figure 35 Displays 
the SDS gel for this purification, which was successful in getting some 
protein, further optimization of expression and sonication conditions would 
lead to protein with minimal degradation. 
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Characterization 
Fluorescence Correlation Spectroscopy 
 
 
 
Figure 39- FCS data for IQGAP1 and PIP2, 
addition of PIP2 causes a change in the diffusion 
coefficient, although there was high inaccuracy 
using this method. 
Figure 40-- FCS data for IQGAP1-C and 
PIP2, addition of PIP2 causes a change in 
the diffusion coefficient, although there was 
high inaccuracy using this method. 
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Model Membrane Binding Study 
 
 
Figure 43- Additional FRET data for 98% PC and 2% d-PE. This data has been 
normalized, and the lack of decrease in the tryptophan emission indicates that 
tryptophan is not being quenched, therefore binding is not occurring. 
Figure 42-- Additional FRET data for 98% PC and 2% d-PE. This data has been 
normalized, and the lack of decrease in the tryptophan emission indicates that 
tryptophan is not being quenched, therefore binding is not occurring. 
Figure 41- Additional FRET data for 98% PC and 2% d-PE. This data has been 
normalized, and the lack of decrease in the tryptophan emission indicates that 
tryptophan is not being quenched, therefore binding is not occurring. 
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Figure 45--Additional FRET data for 93% PC, 2% d-PE, and 5% PIP2. This data has been 
normalized to account for dilution when titrating with PIP2. There is a decrease in 
tryptophan emission, indicating that tryptophan’s fluorescence is being quenched. There -
fore binding is occurring between PIP2 and IQGAP1-C. 
 
Figure 44-Additional FRET data for 93% PC, 2% d-PE, and 5% PIP2. This data has 
been normalized to account for dilution when titrating with PIP2. There is a decrease in 
tryptophan emission, indicating that tryptophan’s fluorescence is being quenched. There 
-fore binding is occurring between PIP2 and IQGAP1-C. 
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Figure 47--Additional FRET data for 63% PC, 30% PS, 2% d-PE, and 5% PIP2. This 
data has been normalized to account for dilution when titrating with PIP2. There is a 
decrease in tryptophan emission, indicating that tryptophan’s fluorescence is being 
quenched. There -fore binding is occurring between PIP2 and IQGAP1-C. 
Figure 46---Additional FRET data for 63% PC, 30% PS, 2% d-PE, and 5% PIP2. This data 
has been normalized to account for dilution when titrating with PIP2. There is a decrease in 
tryptophan emission, indicating that tryptophan’s fluorescence is being quenched. There -fore 
binding is occurring between PIP2 and IQGAP1-C. 
 
